Back

Soluble ST2 as a dynamic biomarker of biological response after transcatheter tricuspid valve intervention

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Tricuspid and mitral valve disease: from imaging and biomarkers to surgical and transcatheter outcomes Tricuspid Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Christoph Edlinger

Salzburg university hospital, Salzburg (Austria)

5 More presentations in this session

Presentation thumbnail
National trends and in-hospital outcomes of tricuspid valve surgery in Germany from 2011 to 2023
Doctor K. Epe (Kiel, DE)
Abstract Slides Video
Presentation thumbnail
Redefining the assessment of secondary tricuspid regurgitation based on novel 3D parameters: an echocardiographic approach to risk stratification
Doctor A. Negru (Cluj Napoca, RO)
Abstract Slides Video
Presentation thumbnail
Functional, echocardiographic outcomes and complications after Transcatheter Tricuspid Edge-to-Edge Repair (T-TEER): a systematic review and meta-analysis
Doctor M. Caria (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Treatment trajectories and procedural outcomes of patients with significant mitral annular calcification and mitral valve disease
Doctor L. Strotmann (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Differential impact of transcatheter tricuspid valve interventions on right heart reverse remodelling: systematic review.
Doctor M. Jawed (Dublin, IE)

Access the full session

Session thumbnail
Tricuspid and mitral valve disease: from imaging and biomarkers to surgical and transcatheter outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Beyond NT-proBNP: novel biomarkers enhance short- and intermediate-term risk prediction in tricuspid valve interventions
1 September 2025
thumbnail
Congress Presentation
Relationship of plasma ST2 level with anatomical features of coronary artery lesion in patients with NSTEMI
18 March 2022
thumbnail
Congress Presentation
sST2 and NT-proBNP levels depending on presence of iron deficiency in patients with acute decompensated heart failure
29 June 2021
thumbnail
Congress Presentation
Soluble ST2 biomarker utility in the comprehension of the clinical course of atrial fibrillation
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources